Skip to main content
. 2022 Jan 3;11:778774. doi: 10.3389/fonc.2021.778774

Figure 1.

Figure 1

(A) Flow chart for screening patients. (B) Numbers of patients with different pathological subtypes in the entire cohort. (C) Numbers of patients with different pathological subtypes in the Endostar combined with chemotherapy group. (D) Numbers of patients with different pathological subtypes in the traditional chemotherapy group.